VHAC provides essential capacity to help CDC meet the agency’s priorities for viral hepatitis prevention. Through both in-kind collaborations and project support, VHAC partnerships have improved educational programs, strengthened the evidence base needed to guide prevention, and supported technical assistance to guide implementation of interventions in the United States and globally. 

Abbott Laboratories
Association of State and Territorial Health Officials
Bristol-Myers Squibb
CDC Foundation
Gilead Sciences, Inc.
Janssen Therapeutics
Merck Sharp & Dohme
National Viral Hepatitis Roundtable
OraSure Technologies
Quest Diagnostics
Siemens Healthcare Diagnostics